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Background
In Nigeria, malaria accounts for 60% of outpatient visits,
30% hospitalization, and is estimated to be responsible
for about 11% of overall maternal mortality, 25% of
infant mortality, and 30% of under-five mortality [1].
The disease is particularly virulent among pregnant
women and the under-five years of age, due to their low
levels of immunity. It impedes economic growth and
keeps households in poverty. Lack of access to diagnos-
tic testing before treatment is one of the weaknesses in
the management of malaria in Nigeria [2]. This study
examines the treatment practice for malaria among
health care providers (HCPs) in Port Harcourt.
Materials and methods
This was a cross-sectional study among HCPs, and data
collection was by use of pre-validated questionnaires
and in-depth interviews. The data was analyzed using
SPSS Version 17.
Results
A total of 273 HCPs (doctors, nurses, pharmacists, com-
munity health workers (CHWs) and private medicine
vendors (PMVs)) were randomly selected from health
care facilities in Port Harcourt. Of the HCPs, 100% of
doctors & pharmacists; 89.6% nurses; 33.3% PMVs; and
25% CHWs are aware of the World Health Organizations
(WHO) treatment guidelines. The ACTs (69.2%) and sul-
phadoxine / pyrimethamine (7.7%) were the most pre-
scribed drugs for uncomplicated malaria in children.
Other drugs prescribed were: Chloroquine, Quinine, and
Artesunate (group 1), 5.1%; and Pyrimethamine and
Paracetamol (group 2), 2.6%. For severe malaria in
children, Quinine (46.2%), the ACTs (20.5%) and intrave-
nous artemether (12.8%) were mostly used. The other
drugs prescribed were those in groups 1 and 2 above. For
uncomplicated malaria in adults, the ACTs (66.7%) and
sulphadoxine /pyrimethamine (17.9%) were most pre-
scribed in addition to the other drugs in groups 1 and 2.
For severe malaria in adults, Quinine (46.2%), the ACTs
(20.5%) and intravenous artemether (12.8%) were mostly
prescribed. For pregnant women, sulphadoxine /pyri-
methamine (76.9%), the ACTs (10.3%), Artesunate (7.7%)
and Quinine (5.1%) were mostly prescribed. Regarding
adherence to WHO treatment guidelines, only 44.3% of
HCPs [doctors, 52.1%; Nurses, 23.1%; Pharmacists,
11.6%; PMVs, 7.4% and CHWs, 6.0%] used diagnostic
testing before treatment. Proximity to a good laboratory,
laboratory costs, and availability of diagnostic tools are
major factors that influence HCPs’ decisions in carrying
out proper diagnosis before treatment.
Conclusion
This study shows that, while the ACTs are widely used for
the treatment of malaria in Nigeria, a larger proportion of
the treatment is not based on diagnostic evaluation. Many
HCPs recognize that diagnostic testing should precede
treatment, but do not have the required facilities for it.
Published: 15 October 2012
References
1. Roll Back Malaria Partnership, WHO: Focus on Nigeria: Progress & Impact
Series. Country Reports 2012, 4:58.
2. National Malaria Control Programme Federal Ministry of Health, Nigeria:
Implementation Guide for Parasite-Based Diagnosis of Malaria. 2011
[http://nmcpnigeria.org/f/case-management/IMPLEMENTATION%20GUIDE%
20FOR%20RDT%20DEPLOYMENT%20MAR_2011.pdf], 19.
Center for Malaria Research and Phytomedicine; University of Port Harcourt,
Rivers State, Nigeria
Ebong et al. Malaria Journal 2012, 11(Suppl 1):P28
http://www.malariajournal.com/content/11/S1/P28
© 2012 Ebong et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
doi:10.1186/1475-2875-11-S1-P28
Cite this article as: Ebong et al.: Antimalarial treatment by health care
providers in Port Harcourt, Nigeria. Malaria Journal 2012 11(Suppl 1):P28.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ebong et al. Malaria Journal 2012, 11(Suppl 1):P28
http://www.malariajournal.com/content/11/S1/P28
Page 2 of 2
